複雑な疾患と遺伝性疾患に関する研究

Complex and Genetic Disease Research

Complex diseases are caused by a combination of genetic and environmental factors, many of which are not fully understood. Although some complex diseases can be highly heritable, many do not follow specific, clear models of inheritance and are not often the result of a single mutated gene. In fact, >90% of disease associated variants are located in non-coding regions of the genome.1 Roughly 5% of complex diseases are caused by monogenic inheritence, while the vast majority is polygenic.2 Autoimmune and rheumatic diseases, atherosclerosis and many forms of heart disease, neurological disorders, and psychiatric disorders are all types of disease that fall into this category.

Given their multifactorial nature, researching complex diseases has proven challenging. Luckily, genomics technologies, including arrays and next-generation sequencing (NGS), are helping accelerate research and are paving the way to achieve greater understanding of disease etiology and, hopefully one day, the diagnosis, treatment, and prevention of these diseases.

Featured Research Stories

先住民族の科学者がデータをどのように管理しているか
先住民族の科学者がデータをどのように管理しているか

次世代シーケンサーは、自治権と遺伝子研究を持つ先住民の国々を支援しています

記事を読む
FMRIはイルミナの新しいエクソーム濃縮を用いてゲノム研究の効率向上を実現しています
FMRIはイルミナの新しいエクソーム濃縮を用いてゲノム研究の効率向上を実現しています

Future Medicine Research InstituteのChief ResearcherであるSookyoung Kim氏がIllumina DNA Prep with Exome 2.0 Plus Enrichmentの評価結果について語ります。

インタビューを読む
中国の希少疾患コミュニティにおける研究と取り組みの調整
中国の希少疾患コミュニティにおける研究と取り組みの調整

イルミナは、新生児の遺伝性疾患の診断における全ゲノムシーケンスに関する画期的なコンセンサスの実現を支援

記事を読む
See How Genomics Empowers Breakthroughs in Complex and Genetic Disease Research
 

Disease Association Studies

Genome-wide association studies uncover common and rare variants associated with disease

Gene Target Identification and Pathway Analysis

Differential Expression Analysis

Differential expression analysis measures changes in gene expression under different conditions or in response to determinite stimuli.

Expression Anaysis by RNA-Seq Provides:
  • Quantitative changes in expression across the transcriptome in different conditions
  • The ability to profile disease state changes and responses to therapeutics
Quantitative trait loci (QTL)

Quantitative trait loci (QTL) analysis identifies molecular markers that correlate to a quantitative change in a particular trait or dynamic outcome.

QTL Analysis Provides:
  • Immediate insight into a probable biological basis for disease associations
  • Identification of gene networks involved in disease pathogenesis
Epigenetic Analysis

Epigenetic analysis elucidates the biological mechanisms that alter gene activity resulting from non-coding variation and the environment.

Epigenomic Analysis Provides:
  • Insight into disease mechanisms for non-coding variants
  • A genome-wide view of changes and patterns in regulatory mechanisms

Polygenic Risk Scoring

A polygenic risk score represents an approximation of an individual’s genetic risk for disease, based on the sum of the risk alleles for a disease trait, relative to the population.

Polygenic risk scores have the potential to:
  • Stratify patients for clinical trials
  • Stratify samples for cohort analysis
  • Assess an individual’s heritable risk for disease
genectic-match-person
Interested in receiving newsletters, case studies, and information on complex disease genomics? Please enter your email address.